Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), an innovation platform dedicated to accelerating promising health innovations, today announced that its majority-owned subsidiary, Pearsanta, Inc. (“Pearsanta”), has entered into a Market Development Collaboration Agreement (the “Agreement”) with women’s health pioneer Evofem Biosciences, Inc. (“Evofem”) (OTCQB: EVFM) focused on Pearsanta’s blood-based diagnostic test for endometriosis.

BEIJING, Sept. 23, 2024 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced its unaudited financial results for the first quarter ended June 30, 2024.

Expected to operate as a community solar site, selling credits to subscribers.Over 640 homes expected to be provided green energy once operational.Eligible to participate in the NYSUN program to receive NYSERDA incentives.TORONTO, Sept. 23, 2024 /PRNewswire/ - SolarBank Corporation (NASDAQ: SUUN; Cboe CA: SUNN, FSE: GY2) ("SolarBank" or the "Company") announces that it intends to develop a 5.4 MW DC ground-mount solar power project known as the Boyle project (the "Project") on a site located in Broome County, New York. The Project is expected to be eligible for incentives under the New York State Energy Research and Development Authority ("NYSERDA") ...

MIAMI, Sept. 23, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 263,160 shares of the Company's common stock originally issued by the Company on May 29, 2024, each having an original exercise price of $9.50 per share, at an exercise price of $9.875 per share. The closing of the warrant exercise transaction is expected to occur on or about September 24, 2024, subject to satisfaction of customary closing conditions.